Healthy Skepticism Library item: 2502
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
[No authors listed].
Roche turns to DM to boost patient compliance with its weight loss drug.
Dis Manag Advis 2002 Apr; 8:(4):51-4,
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11995433
Abstract:
It can be tough getting patients to take their medicines as prescribed, particularly when there are side-effects or other barriers involved. To get around this problem, Roche decided to develop a DM approach to guide patients taking the organization’s new weight-loss agent, XENICAL. In place now for 15 months, the telephonic program is boosting compliance and getting the intended results.
Keywords:
Anti-Obesity Agents/administration & dosage*
Counseling*
Disease Management*
Drug Industry*
Humans
Lactones/administration & dosage*
Obesity/drug therapy*
Patient Compliance*
Patient Education
Reimbursement Mechanisms
Self Administration
Social Support
Telephone
*analysis
United States
Xenical
Roche
industry perspective
compliance
disease management programs
obesity
INFORMATION FROM INDUSTRY: PATIENTS AND CONSUMERS
PROMOTION IN SPECIFIC THERAPEUTIC AREAS: WEIGHT GAIN AND LOSS
